ARTICLE | Clinical News

Tesetaxel: Phase I started

February 15, 2010 8:00 AM UTC

Genta began an open-label, U.S. Phase II trial in up to 55 patients to evaluate 40 mg oral tesetaxel once every 3 weeks or 50 mg oral tesetaxel weekly for 3 consecutive weeks. Tesetaxel has Orphan Dru...